世界の閉経後骨粗鬆症治療薬市場規模・現状・予測2021-2027

【英語タイトル】Global Postmenopausal Osteoporosis Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR4708)・商品コード:QY21APR4708
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:96
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥518,700見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥778,050見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,037,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、閉経後骨粗鬆症治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他)、用途別市場規模(病院薬局、オンライン薬局、ドラッグストア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・閉経後骨粗鬆症治療薬の市場動向
・企業の競争状況、市場シェア
・閉経後骨粗鬆症治療薬の種類別市場規模(ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他)
・閉経後骨粗鬆症治療薬の用途別市場規模(病院薬局、オンライン薬局、ドラッグストア)
・閉経後骨粗鬆症治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・閉経後骨粗鬆症治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・閉経後骨粗鬆症治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・閉経後骨粗鬆症治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・閉経後骨粗鬆症治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Eli Lilly、Pfizer、F. Hoffman La Roche、Procter & Gamble、Merck)
・結論
【レポートの概要】

Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.
The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease.

Market Analysis and Insights: Global Postmenopausal Osteoporosis Therapeutics Market
The global Postmenopausal Osteoporosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Postmenopausal Osteoporosis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Postmenopausal Osteoporosis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Postmenopausal Osteoporosis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Postmenopausal Osteoporosis Therapeutics market.

Global Postmenopausal Osteoporosis Therapeutics Scope and Market Size
Postmenopausal Osteoporosis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Postmenopausal Osteoporosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Pfizer
F. Hoffman La Roche
Procter & Gamble
Merck

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bisphosphonates
1.2.3 Hormones
1.2.4 Strontium Ranelate
1.2.5 Raloxifene
1.2.6 Denosumab
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postmenopausal Osteoporosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Postmenopausal Osteoporosis Therapeutics Market Perspective (2016-2027)
2.2 Postmenopausal Osteoporosis Therapeutics Growth Trends by Regions
2.2.1 Postmenopausal Osteoporosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Postmenopausal Osteoporosis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Postmenopausal Osteoporosis Therapeutics Industry Dynamic
2.3.1 Postmenopausal Osteoporosis Therapeutics Market Trends
2.3.2 Postmenopausal Osteoporosis Therapeutics Market Drivers
2.3.3 Postmenopausal Osteoporosis Therapeutics Market Challenges
2.3.4 Postmenopausal Osteoporosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Revenue
3.1.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Postmenopausal Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Postmenopausal Osteoporosis Therapeutics Revenue
3.4 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio
3.4.1 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postmenopausal Osteoporosis Therapeutics Revenue in 2020
3.5 Postmenopausal Osteoporosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
3.7 Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Postmenopausal Osteoporosis Therapeutics Breakdown Data by Type
4.1 Global Postmenopausal Osteoporosis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Postmenopausal Osteoporosis Therapeutics Breakdown Data by Application
5.1 Global Postmenopausal Osteoporosis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Postmenopausal Osteoporosis Therapeutics Market Size (2016-2027)
6.2 North America Postmenopausal Osteoporosis Therapeutics Market Size by Type
6.2.1 North America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2027)
6.3 North America Postmenopausal Osteoporosis Therapeutics Market Size by Application
6.3.1 North America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2027)
6.4 North America Postmenopausal Osteoporosis Therapeutics Market Size by Country
6.4.1 North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size (2016-2027)
7.2 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type
7.2.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application
7.3.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country
7.4.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Postmenopausal Osteoporosis Therapeutics Market Size (2016-2027)
9.2 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Type
9.2.1 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Application
9.3.1 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country
9.4.1 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Postmenopausal Osteoporosis Therapeutics Introduction
11.1.4 Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Postmenopausal Osteoporosis Therapeutics Introduction
11.2.4 Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 F. Hoffman La Roche
11.3.1 F. Hoffman La Roche Company Details
11.3.2 F. Hoffman La Roche Business Overview
11.3.3 F. Hoffman La Roche Postmenopausal Osteoporosis Therapeutics Introduction
11.3.4 F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
11.3.5 F. Hoffman La Roche Recent Development
11.4 Procter & Gamble
11.4.1 Procter & Gamble Company Details
11.4.2 Procter & Gamble Business Overview
11.4.3 Procter & Gamble Postmenopausal Osteoporosis Therapeutics Introduction
11.4.4 Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
11.4.5 Procter & Gamble Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Postmenopausal Osteoporosis Therapeutics Introduction
11.5.4 Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bisphosphonates
Table 3. Key Players of Hormones
Table 4. Key Players of Strontium Ranelate
Table 5. Key Players of Raloxifene
Table 6. Key Players of Denosumab
Table 7. Key Players of Others
Table 8. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Postmenopausal Osteoporosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Postmenopausal Osteoporosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions (2022-2027)
Table 14. Postmenopausal Osteoporosis Therapeutics Market Trends
Table 15. Postmenopausal Osteoporosis Therapeutics Market Drivers
Table 16. Postmenopausal Osteoporosis Therapeutics Market Challenges
Table 17. Postmenopausal Osteoporosis Therapeutics Market Restraints
Table 18. Global Postmenopausal Osteoporosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2020)
Table 21. Ranking of Global Top Postmenopausal Osteoporosis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Postmenopausal Osteoporosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
Table 25. Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Eli Lilly Company Details
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Postmenopausal Osteoporosis Therapeutics Product
Table 68. Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Eli Lilly Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Postmenopausal Osteoporosis Therapeutics Product
Table 73. Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. F. Hoffman La Roche Company Details
Table 76. F. Hoffman La Roche Business Overview
Table 77. F. Hoffman La Roche Postmenopausal Osteoporosis Therapeutics Product
Table 78. F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 79. F. Hoffman La Roche Recent Development
Table 80. Procter & Gamble Company Details
Table 81. Procter & Gamble Business Overview
Table 82. Procter & Gamble Postmenopausal Osteoporosis Therapeutics Product
Table 83. Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Procter & Gamble Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Postmenopausal Osteoporosis Therapeutics Product
Table 88. Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Merck Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postmenopausal Osteoporosis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Bisphosphonates Features
Figure 3. Hormones Features
Figure 4. Strontium Ranelate Features
Figure 5. Raloxifene Features
Figure 6. Denosumab Features
Figure 7. Others Features
Figure 8. Global Postmenopausal Osteoporosis Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Postmenopausal Osteoporosis Therapeutics Report Years Considered
Figure 13. Global Postmenopausal Osteoporosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Postmenopausal Osteoporosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players in 2020
Figure 18. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Postmenopausal Osteoporosis Therapeutics Revenue in 2020
Figure 20. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Postmenopausal Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Postmenopausal Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Postmenopausal Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Postmenopausal Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Postmenopausal Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Postmenopausal Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Postmenopausal Osteoporosis Therapeutics Market Share by Region (2016-2027)
Figure 42. China Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Postmenopausal Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Postmenopausal Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Postmenopausal Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Postmenopausal Osteoporosis Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Eli Lilly Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
Figure 63. F. Hoffman La Roche Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
Figure 64. Procter & Gamble Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Postmenopausal Osteoporosis Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Eli Lilly、Pfizer、F. Hoffman La Roche、Procter & Gamble、Merck

★調査レポート[世界の閉経後骨粗鬆症治療薬市場規模・現状・予測2021-2027] (コード:QY21APR4708)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の閉経後骨粗鬆症治療薬市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆